Skip to content
ProPublica Donate
ProPublica Donate

Lieber Institute Inc

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Medical Research / Brain Disorders Research (NTEE)

Donations to this organization are tax deductible.

Summary charts: organization finances over time

Revenue
$28.9M (2023)

Expenses
$31.4M (2023)

Total Assets
$36.7M (2023)

Total Liabilities
$12.7M (2023)

Source: Form 990 tax filings from 2011 to 2023

Tax Filings and Audits by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Audits are required to be submitted by nonprofit organizations that spend $750,000 or more in federal grant money in a fiscal year. "Single audits" look at the entire organization's finances and compliance, while other audits are program specific. Nonprofit Explorer has PDFs of audits for some nonprofits for fiscal year 2015 and later. Audit data is from the Federal Audit Clearinghouse.

Fiscal Year Ending June
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$28,903,115
Expenses
$31,448,930
Net Income
-$2,545,815
Net Assets
$23,965,665
Notable Sources of Revenue Percent of Total Revenue
Contributions $26,098,672
90.3%
Program Services $1,749,804
6.1%
Investment Income $672,185
2.3%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $28,388
0.1%
Net Inventory Sales $0
Other Revenue $354,066
1.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,410,907
7.7%
Professional Fundraising Fees $0
Other Salaries and Wages $11,689,439
37.2%
Assets/Debt
Total Assets $36,656,603
Total Liabilities $12,690,938
Net Assets $23,965,665
Compensation
Key Employees and Officers Compensation Related Other
Daniel R Weinberger (Ceo & Director) $763,001 $0 $26,761
Elaine Jones (Chief Operating Officer) $414,835 $0 $10,250
Thomas Michael Hyde (Chief Medical Officer) $411,393 $0 $26,761
Joel E Kleinman (Assoc. Dir. Of Clinical Sc) $397,458 $0 $26,761
Andrew Maslan (Cfo & Treasurer) $347,452 $0 $32,033
James Barrow (Assoc. Dir. Of Drug Discov) $337,058 $0 $32,049
Brady Maher (Lead Investigator) $213,151 $0 $31,106
Keri Martinowich (Lead Investigator) $203,954 $0 $31,139
Shizhong Han (Lead Investigator, Data Sc) $197,004 $0 $30,931
Gregory Carr (Lead Investigator) $191,487 $0 $31,267
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Steven S Sharfstein Md (Director) $0 $0 $0
Paul B Rothman Md (Director) $0 $0 $0
Geoffrey Simon (Director) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0
Robert Muse (Director) $0 $0 $0
Daniel R Getts (Director) $0 $0 $0
Landon S King (Director) $0 $0 $0

Document Links

Fiscal Year Ending June
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$22,894,222
Expenses
$29,512,998
Net Income
-$6,618,776
Net Assets
$25,304,996
Notable Sources of Revenue Percent of Total Revenue
Contributions $16,080,378
70.2%
Program Services $2,921,001
12.8%
Investment Income $697,583
3.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $2,437,385
10.6%
Net Inventory Sales $0
Other Revenue $757,875
3.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,342,466
7.9%
Professional Fundraising Fees $0
Other Salaries and Wages $10,553,382
35.8%
Assets/Debt
Total Assets $31,106,210
Total Liabilities $5,801,214
Net Assets $25,304,996
Compensation
Key Employees and Officers Compensation Related Other
Daniel R Weinberger (Ceo & Director) $733,926 $0 $25,559
Elaine Jones (Chief Operating Officer) $402,589 $0 $10,250
Thomas Michael Hyde (Chief Medical Officer) $400,557 $0 $25,559
Joel E Kleinman (Assoc. Dir. Of Clinical Sc) $386,209 $0 $25,559
Andrew Maslan (Cfo & Treasurer) $337,916 $0 $30,584
James Barrow (Assoc. Dir. Of Drug Discov) $304,433 $0 $30,462
Brady Maher (Lead Investigator) $201,568 $0 $29,467
Shizhong Han (Lead Investigator, Data Science) $201,271 $0 $29,287
Richard Straub (Sr. Research Scientist) $195,351 $0 $16,060
Keri Martinowich (Lead Investigator) $190,229 $0 $29,438
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Steven S Sharfstein Md (Director) $0 $0 $0
Paul B Rothman Md (Director) $0 $0 $0
Geoffrey Simon (Director) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0
Robert Muse (Director) $0 $0 $0
Daniel R Getts (Director) $0 $0 $0
Landon S King (Director) $0 $0 $0

Document Links

Fiscal Year Ending June
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$35,823,160
Expenses
$27,198,424
Net Income
$8,624,736
Net Assets
$36,807,990
Notable Sources of Revenue Percent of Total Revenue
Contributions $24,381,597
68.1%
Program Services $10,291,170
28.7%
Investment Income $258,185
0.7%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $180,825
0.5%
Net Inventory Sales $0
Other Revenue $711,383
2.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,325,026
8.5%
Professional Fundraising Fees $0
Other Salaries and Wages $9,267,624
34.1%
Assets/Debt
Total Assets $44,686,565
Total Liabilities $7,878,575
Net Assets $36,807,990
Compensation
Key Employees and Officers Compensation Related Other
Daniel R Weinberger (Ceo & Director) $703,475 $0 $24,503
Thomas Michael Hyde (Chief Medical Officer) $402,184 $0 $24,503
Elaine Jones (Chief Operating Officer) $395,284 $0 $10,250
Joel E Kleinman (Assoc. Dir. Of Clinical Sc) $389,504 $0 $24,503
Andrew Maslan (Cfo & Treasurer) $334,684 $0 $30,902
James Barrow (Assoc. Dir. Of Drug Discov) $270,061 $0 $31,237
Richard Straub (Sr. Research Assistant) $195,878 $0 $16,167
Brady Maher (Lead Investigator) $184,981 $0 $30,303
Keri Martinowich (Lead Investigator) $181,501 $0 $29,884
Kari L Stoever (Former Chief Ext. Relations Offic) $176,996 $0 $11,286
Andrew Jaffe (Former Lead Investigator) $176,416 $0 $15,363
John Meyers (Director, It & Db Mgmt.) $176,319 $0 $29,983
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Steven S Sharfstein Md (Director) $0 $0 $0
Paul B Rothman Md (Director) $0 $0 $0
Geoffrey Simon (Director) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0
Robert Muse (Director) $0 $0 $0

Document Links

Fiscal Year Ending June
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$17,247,195
Expenses
$28,499,790
Net Income
-$11,252,595
Net Assets
$25,980,515
Notable Sources of Revenue Percent of Total Revenue
Contributions $11,440,375
66.3%
Program Services $3,261,242
18.9%
Investment Income $1,448,170
8.4%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $209,895
1.2%
Net Inventory Sales $0
Other Revenue $887,513
5.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,258,338
7.9%
Professional Fundraising Fees $0
Other Salaries and Wages $8,876,746
31.1%
Assets/Debt
Total Assets $32,856,647
Total Liabilities $6,876,132
Net Assets $25,980,515
Compensation
Key Employees and Officers Compensation Related Other
Daniel R Weinberger (Ceo & Director) $681,654 $0 $24,981
Thomas Michael Hyde (Chief Medical Officer) $399,073 $0 $25,072
Elaine Jones (Chief Operating Officer) $388,882 $0 $11,261
Joel E Kleinman (Assoc. Dir. Of Clinical Sc) $387,629 $0 $24,981
Andrew Maslan (Cfo & Treasurer) $387,075 $0 $31,791
Kari L Stoever (Chief Ext. Relations Offic) $286,934 $0 $17,887
James Barrow (Assoc. Dir. Of Drug Discov) $247,385 $0 $31,487
Andrew Jaffe (Lead Investigator) $222,352 $0 $22,077
Richard Straub (Sr. Research Assistant) $187,714 $0 $16,796
Brady Maher (Lead Investigator) $186,038 $0 $30,572
Venkata Satyanand Mattay (Former Assoc. Dir. Of Neuroimagin) $168,275 $0 $18,759
Ronald Mckay (Former Director Of Basic Sciences) $113,846 $0 $138
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Steven S Sharfstein Md (Director) $0 $0 $0
Stephen Lieber (Director) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0
Paul B Rothman Md (Director) $0 $0 $0
Robert Muse (Director) $0 $0 $0

Document Links

Fiscal Year Ending June
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$21,791,141
Expenses
$26,379,595
Net Income
-$4,588,454
Net Assets
$38,747,057
Notable Sources of Revenue Percent of Total Revenue
Contributions $14,851,678
68.2%
Program Services $2,607,520
12.0%
Investment Income $2,602,234
11.9%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $1,054,544
4.8%
Net Inventory Sales $0
Other Revenue $675,165
3.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,859,997
7.1%
Professional Fundraising Fees $0
Other Salaries and Wages $8,758,757
33.2%
Assets/Debt
Total Assets $44,500,781
Total Liabilities $5,753,724
Net Assets $38,747,057
Compensation
Key Employees and Officers Compensation Related Other
Daniel R Weinberger (Ceo & Director) $685,256 $0 $33,528
Thomas Michael Hyde (Chief Medical Officer) $371,275 $0 $30,986
Elaine Jones (Chief Operating Officer) $367,794 $0 $10,250
Joel E Kleinman (Assoc. Dir. Of Clinical Science) $355,522 $0 $33,528
Andrew Maslan (Cfo & Treasurer) $314,822 $0 $32,965
Kari L Stoever (Chief Ext. Relations Officer) $280,296 $0 $18,140
Venkata Satyanand Mattay (Assoc. Dir. Of Neuroimaging Core) $266,649 $0 $44,629
Ronald Mckay (Director Of Basic Sciences) $243,924 $0 $10,704
James Barrow (Assoc. Dir. Of Drug Discovery) $242,510 $0 $31,885
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Steven S Sharfstein Md (Director) $0 $0 $0
Stephen Lieber (Director) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Samuel Lieber (Past Treasurer) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0
Paul B Rothman Md (Director) $0 $0 $0
Robert Muse (Director) $0 $0 $0

Document Links

Fiscal Year Ending June
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$20,649,548
Expenses
$26,899,975
Net Income
-$6,250,427
Net Assets
$45,622,734
Notable Sources of Revenue Percent of Total Revenue
Contributions $9,537,511
46.2%
Program Services $5,087,929
24.6%
Investment Income $1,629,698
7.9%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $3,744,401
18.1%
Net Inventory Sales $0
Other Revenue $650,009
3.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,855,666
6.9%
Professional Fundraising Fees $0
Other Salaries and Wages $8,633,308
32.1%
Assets/Debt
Total Assets $52,981,874
Total Liabilities $7,359,140
Net Assets $45,622,734
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Daniel R Weinberger (Ceo & Director) $672,190 $0 $26,994
Thomas Michael Hyde (Chief Medical Officer) $362,116 $0 $27,160
Elaine Jones (Chief Operating Officer) $350,000 $0 $10,905
Joel E Kleinman (Assoc. Dir Of Clinical Science) $346,503 $0 $26,994
Andrew Maslan (Cfo & Treasurer) $308,188 $0 $30,371
Ronald Mc Kay (Director Of Basic Sciences) $302,608 $0 $10,980
Kari L Stoever (Chief Ext. Relations Officer) $273,313 $0 $17,216
Venkata Satyanand Mattay (Assoc Dir Of Neuro Imaging Core) $260,645 $0 $33,968
James Barrow (Assoc Dir Of Drug Discovery) $236,252 $0 $30,683
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Ronald J Daniels (Director) $0 $0 $0
Steven S Sharfstein Md (Director) $0 $0 $0
Stephen Lieber (Director) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Samuel Lieber (Treasurer) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0
Robert Muse (Director) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2017

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending June
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$14,340,702
Expenses
$23,935,074
Net Income
-$9,594,372
Net Assets
$54,943,995
Notable Sources of Revenue Percent of Total Revenue
Contributions $6,953,598
48.5%
Program Services $2,155,884
15.0%
Investment Income $1,368,631
9.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $2,168,233
15.1%
Net Inventory Sales $0
Other Revenue $1,694,356
11.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,487,942
6.2%
Professional Fundraising Fees $0
Other Salaries and Wages $8,615,715
36.0%
Assets/Debt
Total Assets $60,320,805
Total Liabilities $5,376,810
Net Assets $54,943,995
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Daniel Weinberger (Ceo & Director) $642,003 $0 $61,783
Ron Mc Kay (Director Of Basic Sciences) $378,999 $0 $11,073
Joel Kleinman (Assoc. Dir Of Clinical Sc Ience) $341,558 $0 $33,335
Thomas M Hyde (Chief Medical Officer) $338,831 $0 $29,994
Andrew Maslan (Cfo & Treasurer) $315,000 $0 $33,020
Kari Stoever (Chief Ext. Relations Offic Er) $268,300 $0 $11,891
Venkata Mattay (Assoc.Dir Of Neuro Imagin G Core) $260,564 $0 $42,781
James Barrow (Assoc. Dir Of Drug Discov Ery) $233,431 $0 $32,402
Elaine Jones (Chief Operating Officer) $116,667 $0 $310
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Ronald J Daniels (Director) $0 $0 $0
Steven S Sharfstein Md (Director) $0 $0 $0
Stephen Lieber (Director) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Samuel Lieber (Director) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0

Document Links

Fiscal Year Ending June
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$12,934,930
Expenses
$23,755,734
Net Income
-$10,820,804
Net Assets
$60,021,337
Notable Sources of Revenue Percent of Total Revenue
Contributions $7,352,088
56.8%
Program Services $4,406,147
34.1%
Investment Income $302,991
2.3%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $573,329
4.4%
Net Inventory Sales $0
Other Revenue $300,375
2.3%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,310,436
5.5%
Professional Fundraising Fees $0
Other Salaries and Wages $7,670,315
32.3%
Assets/Debt
Total Assets $66,206,784
Total Liabilities $6,185,447
Net Assets $60,021,337
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Daniel Weinberger (Ceo & Director) $603,651 $0 $30,628
Ron Mckay (Director Of Basic Sciences) $378,999 $0 $11,204
Joel Kleinman (Assoc. Dir Of Clinical Science) $335,250 $0 $31,219
Thomas M Hyde (Coo & Secretary) $324,329 $0 $29,506
Andrew Maslan (Cfo & Treasurer) $302,083 $0 $31,706
Venkata Mattay (Investigator) $261,564 $0 $41,073
James Barrow (Assoc. Dir Of Drug Discovery) $229,760 $0 $31,678
Tara Eskandari (Chief Administrtive Officer) $203,775 $0 $12,168
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Ronald J Daniels (Director) $0 $0 $0
Steve Lieber (Director) $0 $0 $0
Samual Lieber (Treasurer) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0

Document Links

Fiscal Year Ending June
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$11,803,016
Expenses
$22,379,478
Net Income
-$10,576,462
Net Assets
$72,430,516
Notable Sources of Revenue Percent of Total Revenue
Contributions $3,257,427
27.6%
Program Services $6,311,029
53.5%
Investment Income $941,613
8.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $1,288,316
10.9%
Net Inventory Sales $0
Other Revenue $4,631
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $2,107,520
9.4%
Professional Fundraising Fees $0
Other Salaries and Wages $7,402,116
33.1%
Assets/Debt
Total Assets $79,790,463
Total Liabilities $7,359,947
Net Assets $72,430,516
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Daniel Weinberger (Ceo & Director) $553,785 $0 $41,697
Ron Mckay (Director Of Basic Sciences) $376,136 $0 $11,194
Joel Kleinman (Assoc. Dir.Of Cli Ncl Sciences) $337,352 $0 $29,499
Thomas M Hyde (Coo & Secretary) $336,955 $0 $27,887
Andrew Maslan (Cfo & Treasurer) $272,861 $0 $27,936
Venkata Mattay (Investigator) $246,073 $0 $38,287
Jim Barrow (Assoc. Dir. Of Drug Discovery) $207,766 $0 $30,290
Richard Straub (Investigator) $162,175 $0 $28,236
John Meyers (Director Of It) $152,670 $0 $29,562
Yankai Jia (Investigator) $149,774 $0 $7,482
Fengyu Zhang (Investigator) $145,352 $0 $25,747
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Ronald J Daniels (Director) $0 $0 $0
Steve Lieber (Director) $0 $0 $0
Constance Lieber (President/Secretary) $0 $0 $0
Samuel Lieber (Treasurer) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0

Document Links

Fiscal Year Ending June
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$9,034,813
Expenses
$20,660,464
Net Income
-$11,625,651
Net Assets
$84,448,958
Notable Sources of Revenue Percent of Total Revenue
Contributions $441,315
4.9%
Program Services $5,000,506
55.3%
Investment Income $1,032,333
11.4%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $1,645,517
18.2%
Net Inventory Sales $0
Other Revenue $915,142
10.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,867,189
9.0%
Professional Fundraising Fees $50,000
0.2%
Other Salaries and Wages $6,590,122
31.9%
Assets/Debt
Total Assets $91,491,249
Total Liabilities $7,042,291
Net Assets $84,448,958
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Daniel R Weinberger (Chief Executive Officer & Director) $502,420 $0 $16,526
Joel Kleinman (Associate Director Of Clinical Sciences) $370,454 $0 $18,079
Ron Mckay (Director Of Basic Sciences) $370,352 $0 $16,394
Thomas M Hyde (Chief Operating Officer & Secretary) $316,071 $0 $25,862
Venkata Mattay (Investigator) $249,789 $0 $40,199
Jim Barrow (Associate Director Of Drug Discovery) $197,907 $0 $30,993
Richard Straub (Investigator) $157,106 $0 $26,657
Jie Zhang (Investigator) $156,032 $0 $9,357
John Meyers (Director Of It) $148,932 $0 $27,901
Fengyu Zhang (Investigator) $143,798 $0 $19,506
Herbert Pardes Md (Chairman Of The Board) $0 $0 $0
Ronald J Daniels (Director) $0 $0 $0
Steve Lieber (Director) $0 $0 $0
Constance Lieber (President/Secretary) $0 $0 $0
Samuel Lieber (Treasurer) $0 $0 $0
Mary Rubin (Director) $0 $0 $0
Tamar Maltz (Director) $0 $0 $0
Milton Maltz (Director) $0 $0 $0
Andrew Maslan See Sched O (Chief Financial Officer & Treasurer) $0 $0 $0

Document Links

Fiscal Year Ending June
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$2,866,597
Expenses
$15,799,963
Net Income
-$12,933,366
Net Assets
$94,668,311
Notable Sources of Revenue Percent of Total Revenue
Contributions $150,000
5.2%
Program Services $527,526
18.4%
Investment Income $1,056,254
36.8%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $48,661
1.7%
Net Inventory Sales $0
Other Revenue $1,084,156
37.8%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,584,142
10.0%
Professional Fundraising Fees $65,000
0.4%
Other Salaries and Wages $4,964,297
31.4%
Assets/Debt
Total Assets $100,309,339
Total Liabilities $5,641,028
Net Assets $94,668,311

Document Links

Fiscal Year Ending June
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$4,184,007
Expenses
$11,000,339
Net Income
-$6,816,332
Net Assets
$107,532,319
Notable Sources of Revenue Percent of Total Revenue
Contributions $953,521
22.8%
Program Services $549,532
13.1%
Investment Income $1,048,088
25.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $153,312
3.7%
Net Inventory Sales $0
Other Revenue $1,479,554
35.4%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,500,664
13.6%
Professional Fundraising Fees $0
Other Salaries and Wages $3,212,197
29.2%
Assets/Debt
Total Assets $112,679,813
Total Liabilities $5,147,494
Net Assets $107,532,319

Document Links

Fiscal Year Ending June
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$22,078,411
Expenses
$3,314,084
Net Income
$18,764,327
Net Assets
$113,239,822
Notable Sources of Revenue Percent of Total Revenue
Contributions $19,786,042
89.6%
Program Services $0
Investment Income $643,005
2.9%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$17,278
Net Inventory Sales $0
Other Revenue $1,666,642
7.5%
Notable Expenses Percent of Total Expenses
Executive Compensation $1,311,277
39.6%
Professional Fundraising Fees $0
Other Salaries and Wages $381,495
11.5%
Assets/Debt
Total Assets $114,673,958
Total Liabilities $1,434,136
Net Assets $113,239,822

Document Links

Fiscal Year Ending June
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »